$788 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 28 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 21.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXK | ACCELERATE DIAGNOSTICS INC | $122,083,000 | +17.2% | 5,425,893 | 0.0% | 15.49% | +13.5% | |
| QDEL | QUIDEL CORP | $78,664,000 | -6.7% | 2,915,633 | 0.0% | 9.98% | -9.7% | |
| OPK | Sell | OPKO HEALTH INC | $70,276,000 | +33.8% | 4,959,335 | -5.7% | 8.92% | +29.5% |
| NXTM | NXSTAGE MEDICAL INC | $64,950,000 | -3.5% | 3,754,343 | 0.0% | 8.24% | -6.6% | |
| THOR | THORATEC CORP | $51,634,000 | +29.1% | 1,232,600 | 0.0% | 6.55% | +24.9% | |
| CMRX | Sell | CHIMERIX INC | $36,329,000 | -6.9% | 963,898 | -0.6% | 4.61% | -9.9% |
| ACOR | Buy | ACORDA THERAPEUTICS INC | $34,770,000 | -17.6% | 1,044,783 | +1.2% | 4.41% | -20.3% |
| TTHI | TRANSITION THERAPEUTICS INC | $33,203,000 | -0.1% | 4,861,321 | 0.0% | 4.21% | -3.3% | |
| TSRO | TESARO INC | $31,936,000 | +54.3% | 556,379 | 0.0% | 4.05% | +49.4% | |
| XON | Buy | INTREXON CORP | $31,423,000 | +209.7% | 692,594 | +87.9% | 3.99% | +199.8% |
| ARAY | Sell | ACCURAY INC | $31,306,000 | +13.4% | 3,366,216 | -8.0% | 3.97% | +9.7% |
| New | RAPTOR PHARACEUTICALS | $29,165,000 | – | 2,683,093 | +100.0% | 3.70% | – | |
| MZOR | Buy | MAZOR ROBOTICS LTDsponsored ads | $24,687,000 | -6.4% | 2,198,270 | +3.4% | 3.13% | -9.4% |
| HNSN | HANSEN MEDICAL INC | $22,644,000 | +56.5% | 26,027,981 | 0.0% | 2.87% | +51.4% | |
| RGLS | New | REGULUS THERAPEUTICS INC | $21,804,000 | – | 1,287,150 | +100.0% | 2.77% | – |
| BIOL | BIOLASE INC | $21,159,000 | -23.0% | 10,474,725 | 0.0% | 2.68% | -25.5% | |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $19,183,000 | -24.3% | 3,284,796 | +1.7% | 2.43% | -26.7% |
| VRML | VERMILLION INC | $14,359,000 | -10.9% | 8,112,182 | 0.0% | 1.82% | -13.8% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $12,008,000 | +136.6% | 5,131,444 | -1.0% | 1.52% | +128.8% |
| WBMD | WEBMD HEALTH CORP | $10,437,000 | +10.8% | 238,103 | 0.0% | 1.32% | +7.2% | |
| AGEN | Buy | AGENUS INC | $5,977,000 | +29.7% | 1,165,184 | +0.3% | 0.76% | +25.5% |
| MBLX | Sell | METABOLIX INC | $4,500,000 | +37.2% | 7,258,106 | -9.3% | 0.57% | +32.8% |
| PTBI | Sell | PLASMATECH BIOPHARMACEUTICAL | $4,236,000 | -54.3% | 1,348,960 | -49.8% | 0.54% | -55.8% |
| BIIB | BIOGEN INC | $3,261,000 | +24.4% | 7,723 | 0.0% | 0.41% | +20.3% | |
| CERS | Sell | CERUS CORP | $2,752,000 | -56.7% | 659,900 | -35.2% | 0.35% | -58.1% |
| EYES | Sell | SECOND SIGHT MED PRODS INC | $2,692,000 | -39.2% | 210,000 | -51.3% | 0.34% | -41.1% |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $2,248,000 | – | 147,895 | +100.0% | 0.28% | – |
| LTS | LADENBURG THALMAN FIN SVCS I | $432,000 | -2.3% | 111,789 | 0.0% | 0.06% | -5.2% | |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -237,077 | -100.0% | -0.03% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -1,942,892 | -100.0% | -2.68% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -1,292,392 | -100.0% | -8.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.